Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today The Launch of STELA: Bioptimus is...

Tantech Holdings Ltd Announces Notice of Allowance from U.S. Patent and Trademark Office for Hanging Cabinet Design Patent

Tantech Holdings Ltd Announces Notice of Allowance from U.S. Patent and Trademark Office for Hanging Cabinet Design Patent

LISHUI, China, March 25, 2026 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) (the "Company" or "Tantech"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and...

Baozun Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

Baozun Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

SHANGHAIMarch 25, 2026 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial...

DPC Dash Ltd Announces Full Year 2025 Financial Results

DPC Dash Ltd Announces Full Year 2025 Financial Results

Revenues increased to RMB5.38 billion, representing 24.8% year-over-year growth Adjusted net profit reached RMB187.9 million, representing 43.3% year-over-year growth Store-level operating profit grew by 18.5%; Adjusted group EBITDA increased by...

Kuaishou Technology Announces Fourth Quarter and Full Year 2025 Financial Results

Kuaishou Technology Announces Fourth Quarter and Full Year 2025 Financial Results

HONG KONG, March 25, 2026 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced its financial results for...

BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States

BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States

BGM0504 shown to be generally well tolerated Overall safety, pk, and efficacy profile supports once-daily oral dosing SUZHOU, China, March 25, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (SSE: 688166, "BrightGene" or "the...

Baguio Green Group Announces 2025 Annual Results

Baguio Green Group Announces 2025 Annual Results

Profit surges 72% to HK$97 million Hits historical high since listing HONG KONG, March 25, 2026 /PRNewswire/ -- Baguio Green Group Limited (''Baguio'' or the ''Group'', Stock Code: 01397.HK) is pleased to announce its annual results for the year...

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis

SHANGHAI, March 25, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class...

Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules

Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules

NEW YORK, March 25, 2026 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS) today announced that it has entered into a definitive agreement with a single institutional investor for a registered direct offering priced...

Fosun Pharma Announces 2025 Annual Results

Fosun Pharma Announces 2025 Annual Results

Innovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock code: 600196.SH; 02196.HK), an innovation-driven global pharmaceutical and...

  • 1
  • ...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • ...
  • 64
  • menu
    menu